Clinical Trial

Ketamine in Central Sensitization

Withdrawn Phase 4
View on ClinicalTrials.gov →
Why the trial stopped
Study never opened
Summary
The purpose of this research study is to see if ketamine infusion during surgery can decrease pain after surgery. Ketamine is a medication commonly used as part of anesthesia during surgery and is approved by the US FDA. Patients will be randomized to either receive standard anesthesia with OR without ketamine. The surgical procedure will be the same regardless of which group patients are randomized to. After surgery, patients will be asked to rate their pain in the post-operative observation unit and at their two-week post-operative visit. No additional visits are required for participation in this study. The investigators estimate the surveys will take approximately 10 minutes to complete.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-16; most recent amendment 2026-05-05.
Status change: Not Yet Recruiting → Withdrawn 2026-05-05
Trial Details
NCT Number NCT07182032
Lead Sponsor University Hospitals Cleveland Medical Center
Conditions Endometriosis, Chronic Pelvic Pain
Start Date 2026-02-01
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-11